(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-METHYLPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE
Compound with spectra: 1 NMR
![(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-METHYLPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE](/api/compound/6E5U8d4aAlL.png?ph=true&h=300&w=458 "(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-METHYLPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE")
| SpectraBase Compound ID | 6E5U8d4aAlL |
|---|---|
| InChI | InChI=1S/C14H16O2/c1-3-12-11-8-14(11,13(15)16-12)10-7-5-4-6-9(10)2/h4-7,11-12H,3,8H2,1-2H3/t11-,12-,14+/m0/s1 |
| InChIKey | VPEAUPCDOWOJTN-SGMGOOAPSA-N |
| Mol Weight | 216.28 g/mol |
| Molecular Formula | C14H16O2 |
| Exact Mass | 216.11503 g/mol |
| Enantiomer InChIKey | VPEAUPCDOWOJTN-BZPMIXESSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-FLUOROPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE
(1S,2R)-1-(2-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-NAPHTHYL)-3-OXABICYCLO-[3.1.0]-HEXANE
o-[1-CARBOXY-1-(2-HYDROXYPROPYL)-3-BUTENYL]BENZOIC ACID, gamma-LACTONE, METHYL ESTER
(1S,2R)-1-(2-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(3Aa, 9ba)-2,3,3a,4,5,9b-hexahydro-1H-benz(E)indene-9b-carboxylic acid, methyl ester
o-[1-Carboxy-1-(2-hydroxypropyl)-3-butenyl]benzoic acid, γ-lactone
Ethyl cis-1-(2-aminophenyl)-2-(4-methoxyphenyl)cyclopropane-1-carboxylate
1-Methoxycarbonyl-benzo-bicyclo(2.2.1)hepta-2,5-diene
(3aS*,8aR*)-3a-Hydroxy-2-methyl-1,2,3,3a,8,8a-hexahydrocyclopent[a]inden-3-one
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |